Gary Remington - Concepedia

Author

Gary Remington

Also Known As

G J Remington, G Remington, G. J. Remington, G. Remington, G.J. Remington, GARY REMINGTON, GJ Remington, Gary J Remington, Gary J. Remington, Gary Remington

1.6K

Publications

26K

Citations

H-Index

204

Concepts

All Affiliations

University of Toronto Centre for Addiction and Mental Health Keio University The Scarborough Hospital Schizophrenia Society of Ontario

About

Gary Remington is an author at University of Toronto specializing in medicine, social sciences, and psychiatry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	50	154	8.5K
2	Health Sciences	17	22	1.3K
3	Public Health	4	4	294
4	Education	1	1	21
5	Engineering	1	1	40

Gary Remington

253

Publications

16K

Citations

H-Index

Page 1

	Year	Citations
Relationship Between Dopamine D<sub>2</sub> Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode Schizophrenia Shitij Kapur, Robert B. Zipursky, Corey Jones, American Journal of Psychiatry	2000	1.1K
A Canadian Multicenter Placebo-Controlled Study of Fixed Doses of Risperidone and Haloperidol in the Treatment of Chronic Schizophrenic Patients Guy Chouinard, B. Jones, Gary Remington, Journal of Clinical Psychopharmacology NeuropsychologyPsychotropic MedicationPsychopharmacologyChronic Schizophrenic PatientsNeuropsychiatry	1993	881
Direct Activation of the Ventral Striatum in Anticipation of Aversive Stimuli Jimmy Jensen, Anthony R. McIntosh, Adrian P. Crawley, Neuron Neurobiological MechanismCognitive ScienceCognitive NeuroscienceBehavioral NeuroscienceAversive Stimuli	2003	456
5-HT<sub>2</sub>and D<sub>2</sub>Receptor Occupancy of Olanzapine in Schizophrenia: A PET Investigation Shitij Kapur, Robert B. Zipursky, Gary Remington, American Journal of Psychiatry	1998	369
Treatment of Schizophrenia With Long-Acting Injectable Risperidone W. Wolfgang Fleischhacker, Mariëlle Eerdekens, Keith Karcher, The Journal of Clinical Psychiatry	2003	287
Effect of inescapable shock on subsequent escape performance: Catecholaminergic and cholinergic mediation of response initiation and maintenance Hymie Anisman, Gary Remington, Lawrence S. Sklar Psychopharmacology Cardiogenic ShockResponse InitiationNeurophysiologyRebound EffectNeuropharmacology	1979	277
Increased Stress-Induced Dopamine Release in Psychosis Romina Mizrahi, Jean Addington, Pablo Rusjan, Biological Psychiatry Stress HormonePsychiatryPsychotic DisorderStress-induced Dopamine ReleaseSchizophrenia	2012	271
Characterizing Coronary Heart Disease Risk in Chronic Schizophrenia: High Prevalence of the Metabolic Syndrome Tony Cohn, Denis Prud’homme, David L. Streiner, The Canadian Journal of Psychiatry	2004	253
High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study Shitij Kapur, Gary Remington, Claire E. Jones, American Journal of Psychiatry	1996	253
Validation of a physical activity assessment tool for individuals with schizophrenia Guy Faulkner, Tony Cohn, Gary Remington Schizophrenia Research Physical ActivityPsychiatric EvaluationPsychiatryPsychotic DisorderExercise	2005	251

Page 1